• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在尼日利亚,开始接受高效抗逆转录病毒治疗(HAART)的艾滋病患者中,年轻、失业和男性性别是死亡率的预测因素。

Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria.

作者信息

DeSilva Malini B, Merry Stephen P, Fischer Philip R, Rohrer James E, Isichei Christian O, Cha Stephen S

机构信息

Mayo Clinic College of Medicine, Mayo Medical School, Rochester, MN, USA.

出版信息

AIDS Care. 2009 Jan;21(1):70-7. doi: 10.1080/09540120802017636.

DOI:10.1080/09540120802017636
PMID:19085222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2849645/
Abstract

This retrospective study identifies risk factors for mortality in a cohort of HIV-positive adult patients treated with highly active antiretroviral therapy (HAART) in Jos, Nigeria. We analyzed clinical data from a cohort of 1552 patients enrolled in a HIV/acquired immune deficiency syndrome treatment program and started on HAART between December 2004 and 30 April 2006. Death was our study endpoint. Patients were followed in the study until death, being lost to follow-up, or the end of data collection, 1 December 2006. Baseline patient characteristics were compared using Wilcoxon Rank Sum Test for continuous variables and Pearson Chi-Square test for categorical variables to determine if certain demographic factors were associated with more rapid progression to death. The Cox proportional hazard multivariate model analysis was used to find risk factors. As of 1 December 2006, a total of 104 cases progressed to death. In addition to the expected association of CD4 count less than 50 at initiation of therapy and active tuberculosis with mortality, the patient characteristics independently associated with a more rapid progression to death after initiation of HAART were male gender, age less than 30 years old, and unemployment or unknown occupation status. Future research is needed to identify the confounding variables that may be amenable to targeted interventions aimed at ameliorating these health disparities.

摘要

这项回顾性研究确定了在尼日利亚乔斯接受高效抗逆转录病毒疗法(HAART)治疗的一组HIV阳性成年患者的死亡风险因素。我们分析了1552名参加HIV/获得性免疫缺陷综合征治疗项目并于2004年12月至2006年4月30日开始接受HAART治疗的患者的临床数据。死亡是我们的研究终点。在研究中对患者进行随访,直至死亡、失访或数据收集结束(2006年12月1日)。使用Wilcoxon秩和检验对连续变量进行基线患者特征比较,使用Pearson卡方检验对分类变量进行比较,以确定某些人口统计学因素是否与更快进展至死亡相关。使用Cox比例风险多变量模型分析来寻找风险因素。截至2006年12月1日,共有104例患者进展至死亡。除了治疗开始时CD4细胞计数低于50以及活动性结核病与死亡率的预期关联外,与HAART治疗开始后更快进展至死亡独立相关的患者特征为男性、年龄小于30岁以及失业或职业状况不明。需要进一步研究以确定可能适合进行针对性干预以改善这些健康差异的混杂变量。

相似文献

1
Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria.在尼日利亚,开始接受高效抗逆转录病毒治疗(HAART)的艾滋病患者中,年轻、失业和男性性别是死亡率的预测因素。
AIDS Care. 2009 Jan;21(1):70-7. doi: 10.1080/09540120802017636.
2
Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.布基纳法索接受抗逆转录病毒治疗的HIV感染患者的死亡决定因素及原因:一项为期五年的回顾性队列研究。
AIDS Care. 2012;24(4):478-90. doi: 10.1080/09540121.2011.630353. Epub 2011 Dec 7.
3
Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.HIV 阳性患者在布基纳法索启动 HAART 后结核病的发病率。
Int J Tuberc Lung Dis. 2010 Mar;14(3):318-23.
4
Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.高效抗逆转录病毒治疗与 HIV/AIDS 患者结核病发病的关联。
Ann Epidemiol. 2018 Dec;28(12):886-892.e3. doi: 10.1016/j.annepidem.2018.03.011. Epub 2018 Mar 28.
5
Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.阿比让开始抗逆转录病毒治疗后活动性结核病的危险因素
Am J Respir Crit Care Med. 2005 Jul 1;172(1):123-7. doi: 10.1164/rccm.200410-1342OC. Epub 2005 Apr 1.
6
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省一个儿科高效抗逆转录病毒治疗队列的初步结果。
BMC Pediatr. 2007 Mar 17;7:13. doi: 10.1186/1471-2431-7-13.
7
The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.高效抗逆转录病毒治疗(HAART)起始时机对HIV合并结核感染患者的影响:一项回顾性队列研究
BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.
8
Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.抗逆转录病毒疗法对结核发病率的影响:巴西的经验,1995-2001 年。
PLoS One. 2007 Sep 5;2(9):e826. doi: 10.1371/journal.pone.0000826.
9
[Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].新疆维吾尔自治区接受抗逆转录病毒治疗的艾滋病患者死亡率及危险因素研究
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Nov;48(11):953-8.
10
Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.在乔治·穆哈里博士医院的茨彭诊所接受抗逆转录病毒治疗的艾滋病毒阳性患者的死亡率和死亡原因。
Pol Arch Med Wewn. 2008 Oct;118(10):548-54.

引用本文的文献

1
A randomized stepped wedge trial of an intensive combination approach to roll back the HIV epidemic in Nigerian adolescents: iCARE Nigeria treatment support protocol.一项在尼日利亚青少年中逆转艾滋病毒流行的强化联合方法的随机阶梯式楔形试验:iCARE 尼日利亚治疗支持方案。
PLoS One. 2023 Jul 7;18(7):e0274031. doi: 10.1371/journal.pone.0274031. eCollection 2023.
2
Effect of Text Messaging Plus Peer Navigation on Viral Suppression Among Youth With HIV in the iCARE Nigeria Pilot Study.短信加同伴导航对 iCARE 尼日利亚试点研究中 HIV 青年患者病毒抑制的影响。
J Acquir Immune Defic Syndr. 2021 Aug 1;87(4):1086-1092. doi: 10.1097/QAI.0000000000002694.
3
Strategies for retention of heterosexual men in HIV care in sub-Saharan Africa: A systematic review.撒哈拉以南非洲地区保持异性恋男性参与艾滋病毒治疗的策略:系统评价。
PLoS One. 2021 Feb 4;16(2):e0246471. doi: 10.1371/journal.pone.0246471. eCollection 2021.
4
Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.南非开普敦凯萨泰地区艾滋病毒阳性患者加入依顺俱乐部后,接受抗反转录病毒疗法的长期病毒学应答:纵向分析。
J Int AIDS Soc. 2020 May;23(5):e25476. doi: 10.1002/jia2.25476.
5
Survival Time and Prognostic Factors of Mortality among Patients with Acquired Immunodeficiency Syndrome in North-East Peninsular Malaysia.马来西亚半岛东北部获得性免疫缺陷综合征患者的生存时间及死亡预后因素
Malays J Med Sci. 2019 Jul;26(4):70-78. doi: 10.21315/mjms2019.26.4.8. Epub 2019 Aug 29.
6
On the Epidemiology and Statistical Analysis of HIV/AIDS Patients in the Insurgency Affected States of Nigeria.尼日利亚受叛乱影响州艾滋病毒/艾滋病患者的流行病学与统计分析
Open Access Maced J Med Sci. 2018 Jul 19;6(7):1315-1321. doi: 10.3889/oamjms.2018.229. eCollection 2018 Jul 20.
7
Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.南非开始抗逆转录病毒治疗的成年人 12 年死亡率。
J Int AIDS Soc. 2017 Sep 25;20(1):21902. doi: 10.7448/IAS.20.1.21902.
8
Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria.尼日利亚北部接受长期抗逆转录病毒治疗的成年人治疗结果中的性别差异。
Int Health. 2017 Jan;9(1):3-10. doi: 10.1093/inthealth/ihw050. Epub 2016 Dec 9.
9
Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis.低收入和中等收入国家抗逆转录病毒治疗中全因死亡率的显著性别差异:一项系统评价和荟萃分析。
J Int AIDS Soc. 2016 Nov 8;19(1):21106. doi: 10.7448/IAS.19.1.21106. eCollection 2016.
10
A Second Look at the Association between Gender and Mortality on Antiretroviral Therapy.重新审视抗逆转录病毒治疗中性别与死亡率之间的关联
PLoS One. 2015 Nov 12;10(11):e0142101. doi: 10.1371/journal.pone.0142101. eCollection 2015.

本文引用的文献

1
Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa.饥饿、等待时间与交通成本:是时候应对非洲抗逆转录病毒治疗依从性面临的挑战了。
AIDS Care. 2007 May;19(5):658-65. doi: 10.1080/09540120701244943.
2
Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.接受高效抗逆转录病毒治疗(HAART)的HIV感染患者在临床、免疫学和病毒学参数方面的性别差异。
AIDS. 2007 Apr 23;21(7):835-43. doi: 10.1097/QAD.0b013e3280b0774a.
3
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.赞比亚基层医疗点抗逆转录病毒疗法的快速推广:可行性与早期成效
JAMA. 2006 Aug 16;296(7):782-93. doi: 10.1001/jama.296.7.782.
4
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.撒哈拉以南非洲地区和北美地区对抗逆转录病毒疗法的依从性:一项荟萃分析。
JAMA. 2006 Aug 9;296(6):679-90. doi: 10.1001/jama.296.6.679.
5
AIDS mortality in a tertiary health institution: A four-year review.一家三级医疗机构的艾滋病死亡率:四年回顾
J Natl Med Assoc. 2006 Jun;98(6):862-6.
6
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.抗逆转录病毒治疗第一年中HIV-1感染患者的死亡率:低收入国家与高收入国家的比较。
Lancet. 2006 Mar 11;367(9513):817-24. doi: 10.1016/S0140-6736(06)68337-2.
7
Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons.高效抗逆转录病毒治疗引入后HIV感染患者的死亡率趋势:对3322名HIV感染者队列的分析
Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-57-62.
8
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.用于估计高效抗逆转录病毒治疗开始对CD4细胞计数影响的边际结构模型。
Am J Epidemiol. 2005 Sep 1;162(5):471-8. doi: 10.1093/aje/kwi216. Epub 2005 Aug 2.
9
From mandatory to voluntary testing: balancing human rights, religious and cultural values, and HIV/AIDS prevention in Ghana.从强制检测到自愿检测:加纳在人权、宗教和文化价值观与艾滋病毒/艾滋病预防之间寻求平衡
Soc Sci Med. 2005 Oct;61(8):1689-700. doi: 10.1016/j.socscimed.2005.03.034.
10
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy.长期高效抗逆转录病毒治疗期间HIV-1感染者临床进展的性别差异
AIDS. 2005 Mar 24;19(6):577-83. doi: 10.1097/01.aids.0000163934.22273.06.